The National Psoriasis Foundation has defined acceptable response criteria as an achievement of BSA 3% or less or a BSA improvement of 75% or greater from baseline, and noted the importance of establishing treatment goals to improve the care of patients with psoriasis.
Regardless of the type of therapy being initiated, psoriasis experts agree that a follow-up evaluation should be performed 3 months after treatment initiation to assess tolerability and clinical response. Regular follow-up evaluations should be performed every 6 months thereafter.
Escalation to a biologic medication may be considered for patients who have an inadequate response to oral systemic agents at any point during treatment.
For additional information, refer to the British Association of Dermatologists guidelines for biologic therapy for psoriasis, the Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with biologics, and the Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
Learn more about systemic and biologic treatments for plaque psoriasis.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Chris G. Adigun, William James. Fast Five Quiz: Systemic Treatments for Plaque Psoriasis - Medscape - Dec 21, 2021.